MedTrace Logo

PGx Study to Develop and Validate the Predictive Warfarin Dosing Algorithm for Personalized Warfarin Pharmacotherapy

NCT01178502 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 405

Last updated 2013-06-03

No results posted yet for this study

Summary

To develop and validate the predictive warfarin dosing algorithm.

Conditions

  • Heart Valve Diseases

Sponsors & Collaborators

  • Inje University

    lead OTHER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01178502 on ClinicalTrials.gov